Back to Search Start Over

Surgical management of headache and facial pain/pressure in chronic rhinosinusitis: A systematic review and meta-analysis.

Authors :
Heiland LD
Marrero-Gonzalez AR
Nguyen SA
Farmer HG
Rathi VK
Soler ZM
Schlosser RJ
Source :
International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2024 Sep; Vol. 14 (9), pp. 1465-1476. Date of Electronic Publication: 2024 May 13.
Publication Year :
2024

Abstract

Background: Headache and facial pain are common symptoms of chronic rhinosinusitis (CRS). However, given the numerous etiologies that can cause these symptoms, the impact of sinus surgery is not well characterized.<br />Methods: A systematic review was performed by searching the literature from inception through June 6, 2023. English-language articles reporting outcomes for facial pain/pressure or headache following endoscopic sinus surgery were selected for inclusion. Meta-analyses were performed using random and fixed effect models on continuous measures (mean), mean difference (Δ), and proportions (%).<br />Results: A total of 26 articles reporting on 2839 patients were selected for inclusion. The mean patient age was 44.0 ± 3.9 (range 16.0-84.0), with an average symptom duration of 5.3 ± 2.8 years. Among these patients, 56.5% (95% confidence interval [CI]: 52.3-60.6) were male and 77.0% (95% CI: 56.6-92.3) had nasal polyposis (NP). Patients with and without NP reported substantial reductions in both 22-item sino-nasal outcome test facial pain/pressure (with NP: -1.4 [95% CI: -1.6 to -1.2; relative reduction 59.1%]; without NP: -1.5 [95% CI: -1.9 to -1.1; relative reduction 60.9%]) and visual analogue scale (VAS) headache (with NP: -2.5 [95% CI: -2.8 to -2.1; relative reduction 67.2%]; without NP: -2.8 [95% CI: -4.7 to -1.0; relative reduction 42.7%]). Symptom reductions were greater in the without NP versus with NP group; VAS facial pain/pressure: Δ0.4 (95% CI: 0.2-0.6; p = 0.0006) and VAS headache: Δ0.4 (95% CI: 0.1-0.7; p = 0.02).<br />Conclusions: Our findings suggest that CRS patients, regardless of polyp status, benefit from significant reductions in facial pain/pressure and headache following surgical therapy.<br /> (© 2024 ARS‐AAOA, LLC.)

Details

Language :
English
ISSN :
2042-6984
Volume :
14
Issue :
9
Database :
MEDLINE
Journal :
International forum of allergy & rhinology
Publication Type :
Academic Journal
Accession number :
38739100
Full Text :
https://doi.org/10.1002/alr.23359